LifeMD, Inc. (NASDAQ:LFMDP – Get Free Report) was the target of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 300 shares, an increase of 200.0% from the September 30th total of 100 shares. Based on an average daily trading volume, of 2,100 shares, the short-interest ratio is currently 0.1 days.
LifeMD Price Performance
NASDAQ:LFMDP opened at $22.23 on Monday. The firm has a 50 day simple moving average of $22.17 and a 200-day simple moving average of $22.18. LifeMD has a 1-year low of $17.15 and a 1-year high of $25.00.
LifeMD Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Investors of record on Friday, October 4th were issued a $0.5547 dividend. The ex-dividend date was Friday, October 4th. This represents a $2.22 dividend on an annualized basis and a yield of 9.98%.
About LifeMD
LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.
Read More
- Five stocks we like better than LifeMD
- Trading Halts Explained
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Buy P&G Now, Before It Sets A New All-Time High
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Consumer Staples Stocks, Explained
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.